MDPI and ACS Style
Zhang, Y.; Yang, Y.; Liang, H.; Liang, Y.; Xiong, G.; Lu, F.; Yang, K.; Zou, Q.; Zhang, X.; Du, G.;
et al. Nobiletin, as a Novel PDE4B Inhibitor, Alleviates Asthma Symptoms by Activating the cAMP-PKA-CREB Signaling Pathway. Int. J. Mol. Sci. 2024, 25, 10406.
https://doi.org/10.3390/ijms251910406
AMA Style
Zhang Y, Yang Y, Liang H, Liang Y, Xiong G, Lu F, Yang K, Zou Q, Zhang X, Du G,
et al. Nobiletin, as a Novel PDE4B Inhibitor, Alleviates Asthma Symptoms by Activating the cAMP-PKA-CREB Signaling Pathway. International Journal of Molecular Sciences. 2024; 25(19):10406.
https://doi.org/10.3390/ijms251910406
Chicago/Turabian Style
Zhang, Yan, Yaping Yang, Huicong Liang, Yuerun Liang, Guixin Xiong, Fang Lu, Kan Yang, Qi Zou, Xiaomin Zhang, Guanhua Du,
and et al. 2024. "Nobiletin, as a Novel PDE4B Inhibitor, Alleviates Asthma Symptoms by Activating the cAMP-PKA-CREB Signaling Pathway" International Journal of Molecular Sciences 25, no. 19: 10406.
https://doi.org/10.3390/ijms251910406